Our Clinical Trials
Medicine is a science that constantly evolves. Every device, drug, or new treatment technique is tested first in theory, then in laboratories, on humans in a very tightly controlled environment, and then eventually extended to large populations across the world.
Our clinical trials are all research investigations in which people volunteer to participate to test new treatments, interventions or tests that aim to prevent, detect, treat or manage cancer. Some investigations look at how people respond to a new treatment and what side effects might occur to help determine if a new treatment works, if it is safe, and if it is better than treatments already available.
NECTA's clinical trials are carefully administered by highly skilled medical practitioners and underpinned by robust and stringent governance.
Eligibility Criteria
Each trial is very unique in its requirements – both for the type(s) of cancer treated and the types of patients that are needed. The types of trials that NECTA specialise in are called “early phase trials” and are generally those where other standard treatment options have already been exhausted.
Participating in a Trial
If you are considering participation in a clinical trial, please consult with your doctor or oncologist about your treatment plans. NECTA welcomes enquiries from treating doctors for patients who may be suitable for participation in an early phase clinical trial. Our aim is to help find patients suitable trials across our network of treatment centres.
Partnering on a Trial
Our consortium is very open to discussing mechanisms of partnering with local, national and international hospitals in bringing cutting-edge care to all Australian cancer sufferers. We regularly interact with both pharmaceutical firms and contract research organisations to advocate for Australian cancer patients.
Information on research ethics
Our clinical trials are all research investigations in which people volunteer to participate to test new treatments, interventions or tests that aim to prevent, detect, treat or manage cancer. Some investigations look at how people respond to a new treatment and what side effects might occur to help determine if a new treatment works, if it is safe, and if it is better than treatments already available.
NECTA's clinical trials are carefully administered by highly skilled medical practitioners and underpinned by robust and stringent governance.
Eligibility Criteria
Each trial is very unique in its requirements – both for the type(s) of cancer treated and the types of patients that are needed. The types of trials that NECTA specialise in are called “early phase trials” and are generally those where other standard treatment options have already been exhausted.
Participating in a Trial
If you are considering participation in a clinical trial, please consult with your doctor or oncologist about your treatment plans. NECTA welcomes enquiries from treating doctors for patients who may be suitable for participation in an early phase clinical trial. Our aim is to help find patients suitable trials across our network of treatment centres.
Partnering on a Trial
Our consortium is very open to discussing mechanisms of partnering with local, national and international hospitals in bringing cutting-edge care to all Australian cancer sufferers. We regularly interact with both pharmaceutical firms and contract research organisations to advocate for Australian cancer patients.
Information on research ethics